Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with β Thalassemia: Impact on Outcome and Risk Factors

Wanxia Tan, Yuelin He, MD, Xiaoqin Feng, Xuedong Wu, MD PhD, Chunfu Li, MD, Jianyun Liao, MD, Huaying Liu, MD, Xuan Liu, Fuyu Pei, Qiujun Liu, Xiaoting Liu, Yuqiong Ren

Blood (2020) 136 (Supplement 1): 48–49.

https://doi.org/10.1182/blood-2020-134448

Published: 2020

Journal Articles

Complementary Transplantation Improved Results of Both Peripheral Blood Stem Cells and Unrelated Cord Blood Transplants in Thalassemia: A Multi-Center Study from China

Chunfu Li, MD, Sixi Liu, MD PhD, Yuelin He, MD, Xiaodong Wang, MD, Jianyun Liao, MD, Shan Li, MD, Xiaolin Zheng, MD, Xuedong Wu, MD PhD, Changgang Li, MD, Xiaoqin Feng, Feiqiu Wen, MD PhD, Huaying Liu, MD, Xiaohui Zhou, MD, Zhiyong Peng, MD, Lan He, MD, Chaoke Bu, MD, Leung Wing, MD PhD

Blood (2019) 134 (Supplement_1): 4617.

https://doi.org/10.1182/blood-2019-129697

Published: 2019

Journal Articles

Complementary Transplantation with Unrelated Cord Blood Following Haploidentical Stem Cells for Juvenile Myelomonocytic Leukemia:Double-Centers Study from China

Zhiyong Peng, MD, Xiaoqin Feng, Huaying Liu, MD, Jianyun Liao, MD, Chaoke Bu, Yuelin He, MD, Jianmin Zhang, MD, Jingyu Gao, Chunfu Li, MD

Blood (2019) 134 (Supplement_1): 4181.

https://doi.org/10.1182/blood-2019-128331

Published: 2019

Journal Articles

Donor Lymphocyte Infusion Prevented Late Post-Transplant Rejection in 30 Patients with Thalassemia Major

Jianyun Liao, MD, Xiaoting Liu, Yuelin He, MD, Zhiyong Peng, MD, Huaying Liu, MD, Chunfu Li, MD

Blood (2018) 132 (Supplement 1): 2344.

https://doi.org/10.1182/blood-2018-99-118142

Published: 2018

Journal Articles

A Novel Therapy Protocol Improves Outcomes of Hematopoietic Stem Cell Transplantation in Juvenile Myelomonocytic Leukemia Patients Using Hypomethylation of Decitabine

Zhiyong Peng, MD, Xiaoqin Feng, PhD, Huaying Liu, MD, Yuelin He, Jianyun Liao, MD, Xiaoting Liu, Chunfu Li, MD

Blood (2018) 132 (Supplement 1): 5778.

https://doi.org/10.1182/blood-2018-99-114777

Published: 2018

Journal Articles

Rituximab Combined with Donor Lymphocyte Infusion Cured Immunohemolysis after Refractory Hematopoietic Stem Cell Transplantation

Jianyun Liao, MD, Zhiyong Peng, MD, Huaying Liu, MD, Yuelin He, MD, Chunfu Li, MD

Blood (2018) 132 (Supplement 1): 5745.

https://doi.org/10.1182/blood-2018-99-120163

Published: 2018

NARROW

Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with β Thalassemia: Impact on Outcome and Risk Factors

Complementary Transplantation Improved Results of Both Peripheral Blood Stem Cells and Unrelated Cord Blood Transplants in Thalassemia: A Multi-Center Study from China

Complementary Transplantation with Unrelated Cord Blood Following Haploidentical Stem Cells for Juvenile Myelomonocytic Leukemia:Double-Centers Study from China

Donor Lymphocyte Infusion Prevented Late Post-Transplant Rejection in 30 Patients with Thalassemia Major

A Novel Therapy Protocol Improves Outcomes of Hematopoietic Stem Cell Transplantation in Juvenile Myelomonocytic Leukemia Patients Using Hypomethylation of Decitabine

Rituximab Combined with Donor Lymphocyte Infusion Cured Immunohemolysis after Refractory Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with β Thalassemia: Impact on Outcome and Risk Factors

Complementary Transplantation Improved Results of Both Peripheral Blood Stem Cells and Unrelated Cord Blood Transplants in Thalassemia: A Multi-Center Study from China

Complementary Transplantation with Unrelated Cord Blood Following Haploidentical Stem Cells for Juvenile Myelomonocytic Leukemia:Double-Centers Study from China

Donor Lymphocyte Infusion Prevented Late Post-Transplant Rejection in 30 Patients with Thalassemia Major

A Novel Therapy Protocol Improves Outcomes of Hematopoietic Stem Cell Transplantation in Juvenile Myelomonocytic Leukemia Patients Using Hypomethylation of Decitabine

Rituximab Combined with Donor Lymphocyte Infusion Cured Immunohemolysis after Refractory Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only